<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib80">
 <label>80</label>
 <mixed-citation publication-type="other" id="sref80">Alatovic J. BIONTECH AND PFIZER ANNOUNCE COMPLETION OF DOSING FOR FIRST COHORT OF PHASE 1/2 TRIAL OF COVID-19 VACCINE CANDIDATES IN GERMANY. Pfizer. [April 29 2020. ]. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://investors.pfizer.com/investor-news/press-release-details/2020/BioNTech-and-Pfizer-announce-completion-of-dosing-for-first-cohort-of-Phase-1-2-trial-of-COVID-19-vaccine-candidates-in-Germany/default.aspx" id="intref0195" xmlns:xlink="http://www.w3.org/1999/xlink">https://investors.pfizer.com/investor-news/press-release-details/2020/BioNTech-and-Pfizer-announce-completion-of-dosing-for-first-cohort-of-Phase-1-2-trial-of-COVID-19-vaccine-candidates-in-Germany/default.aspx</ext-link>.
 </mixed-citation>
</ref>
